Researcher
Samir Kumar-Singh
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Infectious diseases, Anatomical pathology, Neurological and neuromuscular diseases, Clinical genetics and molecular diagnostics
Affiliations
- Laboratory of Medical Microbiology (LMM) (Research group)
Member
From1 Jan 2019 → Today - Laboratory of cell biology and histology (Research group)
Member
From1 Oct 2011 → Today - Translational Neurosciences (TNW) (Research group)
Member
From1 Oct 2011 → Today - Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Member
From1 Oct 2011 → 31 Dec 2018 - Department of Biomedical Sciences - other (Research group)
Member
From1 Mar 2010 → 30 Sep 2011 - VIB CMN - Neurodegenerative Brain Diseases Group (Research group)
Member
From1 Oct 2003 → 28 Feb 2010
Projects
1 - 10 of 30
- Fecal microbiotal transplantation as a method for improving the outcomes of the dual radio- and immunotherapies within a colorectal cancer mouse model.From1 Oct 2022 → TodayFunding: SCK (Study Centre Nuclear Energy)
- Advanced Centre for Advanced Microscopy (ACAM).From1 Jan 2022 → TodayFunding: BOF - research organisations
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Molecular insights in SARS-CoV-2 pathogenesis and epidemiology.From1 Jun 2020 → 31 May 2021Funding: BOF - projects
- High-resolution slide scanner for digital histopathological phenotyping in health and disease.From1 Jan 2020 → 31 Dec 2021Funding: BOF - scientific equipment program
- Multidimensional analysis of the nervous system in health and disease (µNeuro).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- The impact of mixed or polymicrobial flora in the development of ventilator-associated pneumonia.From1 Oct 2019 → 31 May 2022Funding: BOF - doctoral mandates
- The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use (VALUE-Dx).From1 Apr 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing, Foreign industrial entreprises
Publications
11 - 20 of 82
- The dynamic transcriptome during maturation of biofilms formed by methicillin-resistant Staphylococcus aureus(2022)
Authors: Jelle Vlaeminck, Qiang Lin, Basil Britto Xavier, Sarah De Backer, Matilda Berkell, Henri De Greve, Jean-Pierre Hernalsteens, Samir Kumar-Singh, Herman Goossens, Surbhi Malhotra
Pages: 1 - 15 - Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors(2022)
Authors: Angelina Konnova, Fien De Winter, Akshita Gupta, An Hotterbeekx, Matilda Berkell, Laure-Anne Teuwen, Greetje Vanhoutte, Silke Raats, Isolde Van der Massen, Yana Debie, et al.
Pages: 1 - 10 - Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial(2022)
Authors: Gabriel Torrens, Thomas van der Schalk, Sara Cortes-Lara, Leen Timbermont, Ester del Barrio-Tofino, Basil Britto Xavier, Laura Zamorano, Omar Ali, Alexey Ruzin, Herman Goossens, et al.
Pages: 1862 - 1872 - Biomarkers and molecular immunopathology of pneumonia(2022)
Authors: Fien De Winter, Samir Kumar-Singh, An Hotterbeekx
Number of pages: 179 - Host immunity influences the composition of murine gut microbiota(2022)
Authors: Vincent Van Averbeke, Matilda Berkell, Mohamed Mysara, Juan Pablo Rodriguez Ruiz, Basil Britto Xavier, Fien De Winter, Bart 's Jongers, Ravi Kumar Jairam, An Hotterbeekx, Herman Goossens, et al.
Pages: 1 - 15 - Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient(2022)
Authors: Rachel M. Wheatley, Julio Diaz Caballero, Thomas van der Schalk, Fien De Winter, Liam P. Shaw, Natalia Kapel, Claudia Recanatini, Leen Timbermont, Jan Kluytmans, Mark Esser, et al.
Pages: 1 - 11 - Evaluation of the kinetics of antibody response to COVID-19 vaccine in solid organ transplant recipients(2022)
Authors: Maddalena Giannella, Elda Righi, Renato Pascale, Matteo Rinaldi, Natascia Caroccia, Chiara Gamberini, Zaira R. Palacios-Baena, Giulia Caponcello, Maria Cristina Morelli, Mariarosa Tame, et al.
Pages: 1 - 13 - Clinical impact of monoclonal antibodies in the treatment of high-risk patients with SARS-CoV-2 breakthrough infections(2022)
Authors: Alessia Savoldi, Matteo Morra, Alessandro Castelli, Massimo Mirandola, Matilda Berkell, Angelina Konnova, Elisa Rossi, Salvatore Cataudella, Pasquale De Nardo, Elisa Gentilotti, et al.
Pages: 1 - 12 - Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression(2022)
Authors: Alessia Savoldi, Matteo Morra, Pasquale De Nardo, Anna Maria Cattelan, Massimo Mirandola, Vinicio Manfrin, Piergiorgio Scotton, Maria Teresa Giordani, Lucio Brollo, Sandro Panese, et al.
Pages: 1065 - 1076 - Identification of potential urinary metabolite biomarkers of Pseudomonas aeruginosa ventilator-associated pneumonia(2022)
Authors: Bart 's Jongers, An Hotterbeekx, Kenny Bielen, Philippe Vervliet, Jan Boddaert, Erik Fransen, Geert Baggerman, Adrian Covaci, Herman Goossens, Surbhi Malhotra, et al.
Pages: 1 - 11
Patents
1 - 5 of 5
- Identification of subjects at risk of developing ventilator-associated pneumonia (Inventor)
- Identification of subjects at risk of developing ventilator-associated pneumonia (Inventor)
- Detecting and treating dementia (Inventor)
- Detecting and treating dementia (Inventor)
- Detecting and treating dementia (Inventor)